Skip to main content
SpringerLink
Log in

Pharmacologic treatment of rhinitis

  • Published:
Clinical Reviews in Allergy Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Naclerio RM, Meier HL, Adkinson NF, Kagey-Sobotka A, Norman PS, Lichtenstein LM: Mediator release following antigenic nasal challenge. J Allergy Clin Immunol 71:89, 1983

    Article  Google Scholar 

  2. Douglas WW: Histamine and 5-hydroxytryptamine (serotonin) and their antagonists, in Gilman AG, et al (eds): Goodman and Gilman’s The Pharmacologic Basis of Therapeutics. 6th edition. New York, MacMillan, 1980, pp 609–646

    Google Scholar 

  3. Bierman CW, Mongar JL: Antihistamines, in Yaffe SJ (ed): Pediatric Pharmacology, Therapeutic Principles in Practice. New York, Grune & Stratton, 1980, pp 213–232

    Google Scholar 

  4. Seppala T, Nuotto E, Korttila K: Single and repeated dose comparison of three antihistamines and phenylpropanolamine: Psychomotor performance and subjective appraisals of sleep. Br J Clin Pharmacol 12:179–188, 1981

    PubMed  CAS  Google Scholar 

  5. Bye CE, Claridge R, Peck AW, Plowman F: Evidence for tolerance to the central nervous effects of the histamine antagonist, triprolidine, in man. Eur J Clin Pharmacol 12:181–186, 1977

    Article  PubMed  CAS  Google Scholar 

  6. Schaff L, Hendeles L, Weinberger M: Suppression of seasonal allergic rhinitis symptoms with daily hydroxyzine. J Allergy Clin Immunol 63:129–133, 1979

    Article  Google Scholar 

  7. Wong L, Hendeles L, Weinberger M: Pharmacologic prophylaxis of allergic rhinitis: Relative efficacy of hydroxyzine and chlorpheniramine. J Allergy Clin Immunol 67:223–228, 1981

    Article  PubMed  CAS  Google Scholar 

  8. Nicholson AN, Stone BM: Performance studies with the H1 histamine receptor antagonists, astemizole and terfenadine. Br J Clin Pharmacol 13:199–202, 1982

    PubMed  CAS  Google Scholar 

  9. Barone DA, Raniolo J: Facial dyskinesia from overdose of an antihistamine. N Engl J Med 303:107, 1980

    PubMed  CAS  Google Scholar 

  10. Prenner BM: Neonatal withdrawal syndrome associated with hydroxyzine. Am J Dis Child 131:529–530, 1977

    PubMed  CAS  Google Scholar 

  11. Sadusk JF, Palmisano PA: Teratogenic effect of meclizine, cyclizine and chlorcyclizine. JAMA 194:987–989, 1965

    Article  PubMed  Google Scholar 

  12. Reyes-Jacang A, Wenzl JE: Antihistamine toxicity in children. Clin Pediatr 8:297–299, 1969

    Article  CAS  Google Scholar 

  13. Wyngaarden JB, Seevers MH: The toxic effects of antihistaminic drugs. JAMA 145:277–282, 1951

    CAS  Google Scholar 

  14. Huang S-M, Athanikar NK, Sridhar K, et al: Pharmacokinetics of chlorpheniramine after intravenous and oral administration in normal adults. Eur J Clin Pharmacol 22:359–365, 1982

    Article  PubMed  CAS  Google Scholar 

  15. Vallner JJ, Needham TE, Chan W, Viswanathan CT: Intravenous administration of chlorpheniramine to seven subjects. Curr Ther Res 26:449–453, 1979

    CAS  Google Scholar 

  16. Yacobi A, Stoll, RG, Chao GC, et al: Evaluation of sustained-action chlorpheniraminepseudoephedrine dosage forms in humans. J Pharm Sci 69:1077–1081, 1980

    Article  PubMed  CAS  Google Scholar 

  17. Simons FER, Luciuk GH, Simons KJ: Pharmacokinetics and efficacy of chlorpheniramine in children. J Allergy Clin Immunol 69:376–381, 1982

    Article  PubMed  CAS  Google Scholar 

  18. Thompson JA, Bloedow DC, Leffert FH: Pharmacokinetics of intravenous chlorpheniramine in children. J Pharm Sci 70:1284–1286, 1981

    Article  PubMed  CAS  Google Scholar 

  19. Simons FER, Frith EM, Simons KJ: The pharmacokinetics and antihistaminic effects of brompheniramine. J Allergy Clin Immunol 70:458–464, 1982

    Article  PubMed  CAS  Google Scholar 

  20. Simons FER, Simons KJ, Frith EM: The pharmacokinetics and antihistaminic effects of the H1 receptor antagonist hydroxyzine. J Allergy Clin Immunol 73:69–75, 1984

    Article  PubMed  CAS  Google Scholar 

  21. Simons FER, Simons KJ, Becker AB, Haydey RP: The pharmacokinetics and antipruritic effects of hydroxyzine in children with atopic dermatitis. J Pediatr 104:123–127, 1984

    Article  PubMed  CAS  Google Scholar 

  22. Cook TJ, MacQueen DM, Wittig HJ, Thornby JI, Lantos RL, and Virtue CM: Degree and duration of skin test suppression and side effects with antihistamines. J Allergy Clin Immunol 51:71–77, 1973

    Article  PubMed  CAS  Google Scholar 

  23. Rhoades RB, Leiter KN, Cohan R, Wittig HJ: Suppression of histamine-induced pruritus by three antihistaminic drugs. J Allergy Clin Immunol 55:180–185, 1975

    Article  PubMed  CAS  Google Scholar 

  24. Fowle ASE, Hughes DTD, Knight GJ: The evaluation of histamine antagonists in man. Eur J Clin Pharmacol 3:215–220, 1971

    Article  PubMed  CAS  Google Scholar 

  25. Simons KJ, Simons FER, Frith EM: Effect of chronic administration of hydroxyzine on its own disposition in dogs. Abstracts. Am. Pharm. Assoc. Academy of Pharmaceutical Science 13:207, 1983

    Google Scholar 

  26. Diamond L, Gerson K, Cato A, Peace K, Perkins JG: An evaluation of triprolidine and pseudoephedrine in the treatment of allergic rhinitis. Ann Allergy 47:87–91, 1981

    PubMed  CAS  Google Scholar 

  27. Britton MG, Empey DW, John GC, McDonnell KA, Hughes DTD: Histamine challenge and anterior nasal rhinometry: Their use in the assessment of pseudoephedrine and triprolidine as nasal decongestants in subjects with hayfever. Br J Clin Pharmacol 6:51–58, 1978

    PubMed  CAS  Google Scholar 

  28. Thomas JS, Heurich AE, Ralph JW, Crane R, Shepherd DA: Double-blind, controlled study of clemastine fumarate, chlorpheniramine and placebo in patients with seasonal allergic rhinitis. Ann Allergy 38:169–174, 1977

    PubMed  CAS  Google Scholar 

  29. Empey DW, Bye C, Hodder M, Hughes DTD: A double-blind crossover trial of pseudoephedrine and triprolidine, alone and in combination, for the treatment of allergenic rhinitis. Ann Allergy 34:41–46, 1975

    PubMed  CAS  Google Scholar 

  30. Connell JT: A novel method to assess antihistamine and decongestant efficacy. Ann Allergy 42:278–285, 1979

    PubMed  CAS  Google Scholar 

  31. Woodward JK, Munro NL: Terfenadine, the first non-sedating antihistamine. Arzneim-Forsch/Drug Res 32:1154–1156, 1982

    CAS  Google Scholar 

  32. Wilson JD, Hillas JL: Astemizole: A new long-acting antihistamine in the treatment of seasonal allergic rhinitis. Clin Allergy 12:131–140, 1982

    Article  Google Scholar 

  33. Brostoff J, Lockhart JDF: Controlled trial of terfenadine and chlorpheniramine maleate in perennial rhinitis. Postgrad Med J 58:422–423, 1982

    PubMed  CAS  Google Scholar 

  34. Callier J, Engelen RF, Ianniello I, Olzem R, Zeisner M, Amery WK: Astemizole (R43 512) in the treatment of hay fever. An international double-blind study comparing a weekly treatment (10 mg and 25 mg) with a placebo. Curr Ther Res 29:24–35, 1981

    Google Scholar 

  35. Sullivan TJ: Pharmacologic modulation of the whealing response to histamine in human skin: Identification of doxepin as a potent in vivo inhibitor. J Allergy Clin Immunol 69:260–267, 1982

    Article  PubMed  CAS  Google Scholar 

  36. Secher C, Kirkegaard J, Borum P, Maansson A, Osterhammel P, Mygind N: Significance of H1 and H2 receptors in the human nose: Rationale for topical use of combined antihistamine preparations. J Allergy Clin Immunol 70:211–218, 1982

    Article  PubMed  CAS  Google Scholar 

  37. Carpenter GB, Bunker-Soler AL, Nelson HS: Evaluation of combined H1 and H2 receptor blocking agents in the treatment of seasonal allergic rhinitis. J Allergy Clin Immunol 71:412–417, 1983

    Article  PubMed  CAS  Google Scholar 

  38. Brooks CD, Butler D, Metzler C: Effect of H2 blockade in the challenged allergic nose. J Allergy Clin Immunol 70:373–376, 1982

    Article  PubMed  CAS  Google Scholar 

  39. McGuigan JE: A consideration of the adverse effects of cimetidine. Gastroenterology 80:181–192, 1981.

    PubMed  CAS  Google Scholar 

  40. Weiner N: Norepinephrine, epinephrine and the sympathomimetic amines, in,2 pp 138–175

  41. Pelikan Z, deVries K: Effects of some drugs applied topically to the nasal mucosa before nasal provocation tests with allergen. Acta Allergol 29:337–353, 1974

    PubMed  CAS  Google Scholar 

  42. Mujic M, Van Rossum JM: Comparative pharmacodynamics of sympathomimetic imidazolines; Studies of intestinal smooth muscle of the rabbit and the cardiovascular system of the cat. Arch Int Pharmacodyn 155:432–149, 1965

    PubMed  CAS  Google Scholar 

  43. Horowitz JD, Howes LG, Christophidis N, Lang WJ, Fennessy MR, Rand MJ, Louis WJ: Hypertensive responses induced by phenylpropanolamine in anorectic and decongestant preparations. Lancet 1:60–61, 1980

    Article  PubMed  CAS  Google Scholar 

  44. Howrie DL, Wolfson JH: Phenylpropanolamine-induced hypertensive seizures. J Pediatr 102:143–145, 1983

    Article  PubMed  CAS  Google Scholar 

  45. Swenson RD, Golper TA, Bennett WM: Acute renal failure and rhabdomyolysis after ingestion of phenylpropanolamine-containing diet pills. JAMA 248:1216, 1982

    Article  PubMed  CAS  Google Scholar 

  46. Bernstein E, Diskant BM: Phenylpropanolamine: A potentially hazardous drug. Ann Emerg, Med 11:311–315, 1982

    Article  CAS  Google Scholar 

  47. Meyer J, Portmann P: Fluorometric determination of the D-norpseudoephedrine in the plasma. Plasma levels during the resorption from the free and extended-release form. Pharm Acta Helv 57:12–15, 1982

    PubMed  CAS  Google Scholar 

  48. Borum P, Mygind N: Inhibition of the immediate allergic reaction in the nose by the beta-2 adrenostimulant fenoterol. J Allergy Clin Immunol 66:25–32, 1980

    Article  PubMed  CAS  Google Scholar 

  49. Borum P, Mygind N, Schultz Larsen, F: Intranasal ipratropium: A new treatment for perennial rhinitis. Clin Otolaryngol 4:407–411, 1979

    Article  PubMed  CAS  Google Scholar 

  50. Cox JSG: Disodium cromoglycate (FPL 670) (Intal). A specific inhibitor of reaginic antibody-antigen mechanisms. Nature (Lond) 216:1328–1329, 1967

    Article  CAS  Google Scholar 

  51. Theoharides TC, Sieghart W, Greengard P, Douglas WW: Antiallergic drug cromolyn may inhibit histamine secretion by regulating phosphorylation of a mast cell protein. Science 207:80–82, 1980

    Article  PubMed  CAS  Google Scholar 

  52. Lavin N, Rachelefsky GS, Kaplan SA: An action of disodium cromoglycate: Inhibition of cyclic 3′5′-AMP phosphodiesterase. J Allergy Clin Immunol 57:80–88, 1976

    Article  PubMed  CAS  Google Scholar 

  53. Foreman JC, Garland LG: Cromoglycate and other antiallergic drugs: A possible mechanism of action. Br Med J 1:820–821, 1976

    PubMed  CAS  Google Scholar 

  54. Spataro AC, Bosmann HB: Mechanism of action of disodium cromoglycate-mast cell calcium ion influx after a histamine releasing stimulus. Biochem Pharmacol 25:505–510, 1976

    Article  PubMed  CAS  Google Scholar 

  55. Assem ESK, Mongar JL: Inhibition of allergic reactions in man and other species by cromoglycate. Int Arch Allergy Appl Immunol 38:68–77, 1970

    PubMed  CAS  Google Scholar 

  56. Proctor BG, Burford RG, Blair AMJN, MacFarland H: A study of the chronic toxicity of inhaled disodium cromoglycate in the squirrel monkey. Toxicol Appl Pharmacol 25:479, 1973

    Google Scholar 

  57. Smith JM: Disodium cromoglycate in hayfever. Lancet I 295–296, 1971

    Google Scholar 

  58. Holopainen E, Backman A, Salo OP: Effect of disodium cromoglycate on seasonal allergic rhinitis. Lancet I 55–57, 1971

    Article  Google Scholar 

  59. Capel LH, McKelvie P: Disodium cromoglycate in hayfever. Lancet I 575–576, 1971

    Article  Google Scholar 

  60. Engstrom I, Oberger E, Blyckert A, Kraepelien S: Disodium cromoglycate in the treatment of seasonal allergic rhinoconjunctivitis in children. Ann Allergy 29:505–509, 1971

    PubMed  CAS  Google Scholar 

  61. Blair H, Herbert RL: Treatment of seasonal allergic rhinitis with 2% sodium cromoglycate (BP) solution. Clin Allergy 3:283–288, 1973

    Article  PubMed  CAS  Google Scholar 

  62. Illum P, Meistrup-Larsen U, Moesner J, Olesen K, Olsen SZ: Disodium cromoglycate (Lomudal) in the treatment of hay fever. Acta Allergol 28:416–424, 1973

    PubMed  CAS  Google Scholar 

  63. Knight A, Underdown BJ, Demanuele F, Hargreave FE: Disodium cromoglycate in ragweed allergic rhinitis. J Allergy Clin Immunol 58:278–283, 1976

    Article  PubMed  CAS  Google Scholar 

  64. Chandra RK, Heresi G, Woodford G: Double-blind controlled crossover trial of 4% intranasal sodium cromoglycate solution in patients with seasonal allergic rhinitis. Ann Allergy 49:131–134, 1982

    PubMed  CAS  Google Scholar 

  65. Welsh PW, Yunginger JW, Kern EB, Gleich GJ: Preseasonal IgE ragweed antibody level as a predictor of response to therapy of ragweed hay fever with intranasal cromolyn sodium solution. J Allergy Clin Immunol 60:104–109, 1977

    Article  PubMed  CAS  Google Scholar 

  66. Leiferman KM, Yunginger JW, Larson JB, Gleich GJ: The effect of cromolyn sodium powder as a treatment for ragweed pollinosis. J Allergy Clin Immunol 56:481–490, 1975

    Article  PubMed  CAS  Google Scholar 

  67. Handelman NI, Friday GA, Schwartz HJ, Kuhn FS, Lindsay DE, Koors PG, Moyer RP, Smith CS, Kemper CF, Nagel JR, Rosch J, Murphey S, Miller DL: Cromolyn sodium nasal solution in the prophylactic treatment of pollen-induced seasonal allergic rhinitis. J Allergy Clin Immunol 59:237–242, 1977

    Article  PubMed  CAS  Google Scholar 

  68. Tuffiash WA, McLean JA: A trial of 4% cromolyn sodium in seasonal allergic rhinitis. J Allergy Clin Immunol 55:116–117, 1975

    Google Scholar 

  69. Manners B, Ezeoke A: Serum IgE levels and the use of sodium cromoglycate (BP) in hayfever: A study of forty-six patients from a single general practice. Clin Allergy 3:311–318, 1973

    Article  PubMed  CAS  Google Scholar 

  70. Mygind N, Hansen IB, Jorgensen MB: Disodium cromoglycate nasal spray in adult patients with perennial rhinitis. Acta Allergol 27:372–380, 1972

    PubMed  CAS  Google Scholar 

  71. Brain DJ, Singh KP, Trotter CM, Viner AS: Sodium cromoglycate 2 percent solution in perennial rhinitis: A clinical and histological study. J Laryngol Otol 88:1001–1017, 1974

    Article  PubMed  CAS  Google Scholar 

  72. Holopainen E, Viner T, Backman A, Salo O, Hannuksela M, Malmberg H: Clinical trial of a two per cent solution of DSCG in perennial rhinitis. Acta Allergol 30:216–226, 1975

    PubMed  CAS  Google Scholar 

  73. Fagerberg E, Zetterstrom O: A trial of disodium cromoglycate in perennial rhinitis. Acta Allergol 30:63–72, 1975

    PubMed  CAS  Google Scholar 

  74. Cohan RH, Bloom FL, Rhoades RB, Wittig HJ, Haugh LD: Treatment of perennial allergic rhinitis with cromolyn sodium. J Allergy Clin Immunol 58:121–128, 1976

    Article  PubMed  CAS  Google Scholar 

  75. Sheffer AL, Rocklin RE, Goetzl EJ: Immunologic components of hypersensitivity reactions to cromolyn sodium. N Engl J Med 293:1220–1224, 1975

    Article  PubMed  CAS  Google Scholar 

  76. Walker SR, Evans ME, Richards AJ, Paterson JW: The fate of (14C) disodium cromoglycate in man. J Pharm Pharmacol 24:525–531, 1972

    PubMed  CAS  Google Scholar 

  77. Pelikan Z, Snoek WJ, Booij-Noord H, Orie NGM, deVries K: Protective effect of disodium cromoglycate on the allergen provocation of the nasal mucosa. Ann Allergy 28:548–553, 1970

    PubMed  CAS  Google Scholar 

  78. Taylor G, Shivalkar PR: Disodium cromoglycate: Laboratory studies and clinical trial in allergic rhinitis. Clin Allergy 1:189–198, 1971

    Article  PubMed  CAS  Google Scholar 

  79. Chatterjee SS, Nassar WY, Wilson O, Butler AG: Intra-nasal beclomethasone dipropionate and intra-nasal sodium cromoglycate: A comparative trial. Clin Allergy 4:343–348, 1974

    Article  Google Scholar 

  80. Frankland AW, Walker SR: A comparison of intranasal betamethasone valerate and sodium cromoglycate in seasonal allergic rhinitis. Clin Allergy 5:295–300, 1975

    Article  PubMed  CAS  Google Scholar 

  81. Hillas J, Booth RJ, Somerfield S, Morton R, Avery J, Wilson JD: A comparative trial of intranasal beclomethasone dipropionate and sodium cromoglycate in patients with chronic perennial rhinitis. Clin Allergy 10:253–258, 1980

    Article  PubMed  CAS  Google Scholar 

  82. Pelikan Z: The effects of disodium cromoglycate and beclomethasone dipropionate on the late nasal mucosa response to allergen challenge. Ann Allergy 49:200–212, 1982

    PubMed  CAS  Google Scholar 

  83. Pelikan Z, Pelikan-Filipek M: The effects of disodium cromolgycate and beclomethasone dipropionate on the immediate response of the nasal mucosa to allergen challenge. Ann Allergy 49:283–292, 1982

    PubMed  CAS  Google Scholar 

  84. Easty DL, Rice NSC, Jones BR: Clinical trial of topical disodium cromoglycate in vernal kerato-conjunctivitis. Clin Allergy 2:99–107, 1972

    Article  PubMed  CAS  Google Scholar 

  85. Donovan R, Kapadia R: The effect of disodium cromoglycate on nasal polyp symptoms. J Laryngol Otol 86:731–739, 1972

    PubMed  CAS  Google Scholar 

  86. Nelson BL, Jacobs RL: Response of the nonallergic rhinitis with eosinophilia (NARES) syndrome to 4% cromolyn sodium nasal solution. J Allergy Clin Immunol 70:125–128, 1982

    Article  PubMed  CAS  Google Scholar 

  87. Juniper EF, Cartier A, Trebilcock AL, Frith PA, Dolovich J, Hargreave FE: Effects of oxatomide compared with chlorpheniramine in allergic rhinoconjunctivitis. Clin Allergy 11:61–66, 1981

    Article  PubMed  CAS  Google Scholar 

  88. Ganderton MA, James VHT: Clinical and endocrine side-effects of methylprednisolone acetate as used in hay-fever. Br Med J Vol I January 267–269, 1970

  89. Norman PS, Winkenwerder WL: Suppression of hay fever symptoms with intranasal dex-amethasone aerosol. J Allergy 36:284–292, 1965

    Article  CAS  Google Scholar 

  90. Norman PS, Winkenwerder WL, Agbayani BF, Migeon CJ: Adrenal function during the use of dexamethasone aerosols in the treatment of ragweed hay fever. J Allergy 40:57–61, 1967

    Article  PubMed  CAS  Google Scholar 

  91. Czarny D, Brostoff J: Effect of intranasal betamethasone-17-valerate on perennial rhinitis and adrenal function. Lancet 2:188–190, 1968

    Article  PubMed  CAS  Google Scholar 

  92. Blair H, Butler AG: Intranasal beclomethasone dipropionate in seasonal rhinitis in general practice. The Practitioner 216:347–351, 1976

    PubMed  CAS  Google Scholar 

  93. Mygind N: Local effect of intranasal beclomethasone dipropionate aerosol in hay fever. Br Med J 4:464–466, 1973

    PubMed  CAS  Google Scholar 

  94. Hansen IB, Mygind N: Local effect of intranasal beclomethasone dipropionate aerosol in perennial rhinitis. Acta Allergol 29:281–287, 1974

    PubMed  CAS  Google Scholar 

  95. Gibson GJ, Maberly DJ, Lai S, Ali MM, Butler AG: Double-blind cross-over trial comparing intranasal beclomethasone dipropionate and placebo in perennial rhinitis. Br Med J 4:503–504, 1974

    PubMed  CAS  Google Scholar 

  96. Morrow Brown H, Storey G: Beclomethasone dipropionate aerosol in the treatment of seasonal asthma and hay fever. Clin Allergy 4:331–341, 1974

    Article  Google Scholar 

  97. Andersen JB, Halberg P, Mygind N: Beclomethasone dipropionate aerosol treatment of hay fever. Acta Allergol 30:316–325, 1975

    PubMed  CAS  Google Scholar 

  98. Ruff F, Salem A, Boutaric P, Brouet G: A two-stage clinical assessment of beclomethasone dipropionate aerosols. Postgrad Med J 51 (suppl 4):54–57, 1975

    PubMed  Google Scholar 

  99. Vilsvik JS, Jenssen AO, Walstad R: The effect of beclomethasone dipropionate aerosol on allergen induced nasal stenosis. Clin Allergy 5:291–294, 1975

    Article  PubMed  CAS  Google Scholar 

  100. Prahl P, Wilken-Jensen K, Mygind N: Beclomethasone dipropionate aerosol in treatment of hay fever in children. Arch Dis Child 50:875–878, 1975

    Article  PubMed  CAS  Google Scholar 

  101. Morrow Brown H, Storey G: Beclomethasone dipropionate aerosol in treatment of perennial and seasonal rhinitis: A review of five years’ experience. Br J Clin Pharmacol 4:283S-286S, 1977

    Google Scholar 

  102. Lofkvist T, Svensson G: Treatment of vasomotor rhinitis with intranasal beclomethasone dipropionate (Becotide). Acta Allergol 31:227–238, 1976

    PubMed  CAS  Google Scholar 

  103. Malm L, Wihl JA: Intranasal beclomethasone dipropionate in vasomotor rhinitis. Acta Allergol 31:245–253, 1976

    PubMed  CAS  Google Scholar 

  104. Spector SL, English GM, Jones LM: Clinical and nasal biopsy response to treatment of perennial rhinitis. J Allergy Clin Immunol 66:129–137, 1980

    Article  PubMed  CAS  Google Scholar 

  105. Small P, Black M, Frenkiel S: Effects of treatment with beclomethasone dipropionate in subpopulations of perennial rhinitis patients. J Allergy Clin Immunol 70:178–182, 1982

    Article  PubMed  CAS  Google Scholar 

  106. Siegel SC, Katz RM, Rachelefsky GS, Geller BD, Montag LL, Brandon ML, Cannon SJ: Multicentric study of beclomethasone dipropionate nasal aerosol in adults with seasonal allergic rhinitis. J Allergy Clin Immunol 69:345–353, 1982

    Article  PubMed  CAS  Google Scholar 

  107. Tarlo SM, Cockcroft DW, Dolovich J, Hargreave FE: Beclomethasone dipropionate aerosol in perennial rhinitis. J Allergy Clin Immunol 59:232–236, 1977

    Article  PubMed  CAS  Google Scholar 

  108. Cockcroft DW, MacCormack DW, Newhouse MT, Hargreave FE: Beclomethasone dipropionate aerosol in allergic rhinitis. Can Med Assoc J 115:523–526, 1976

    PubMed  CAS  Google Scholar 

  109. Knight A, Kolin A: Long-term efficacy and safety of beclomethasone dipropionate aerosol in perennial rhinitis. Ann Allergy 50:81–84, 1983

    PubMed  CAS  Google Scholar 

  110. Incaudo G, Schatz M, Yamamoto F, Mellon M, Crepea S, Johnson JD: Intranasal flunisolide in the treatment of perennial rhinitis: Correlation with immunologic parameters. J Allergy Clin Immunol 65:41–19, 1980

    Article  PubMed  CAS  Google Scholar 

  111. Turkeltaub PC, Norman PS, Johnson JD, Crepea S: Treatment of seasonal and perennial rhinitis with intranasal flunisolide. Allergy 37:303–311, 1982

    Article  PubMed  CAS  Google Scholar 

  112. Clayton DE, Kooistra JB, Geller M, Ouellette J, Cohen M, Reed CE, Busse W: Short-term efficacy trial and twenty-four month follow-up of flunisolide nasal spray in the treatment of perennial rhinitis. J Allergy Clin Immunol 67:2–7, 1981

    Article  PubMed  CAS  Google Scholar 

  113. Sahay JN, Chatterjee SS, Engler C: Flunisolide—A new intranasal steroid for the treatment of allergic rhinitis. Clin Allergy 9:17–24, 1979

    Article  PubMed  CAS  Google Scholar 

  114. Schultz JI, Johnson JD, Freedman SO: Double-blind trial comparing flunisolide and placebo for the treatment of perennial rhinitis. Clin Allergy 8:313–320, 1978

    Article  Google Scholar 

  115. Horan JD, Johnson JD: Flunisolide nasal sprav in the treatment of perennial rhinitis. Can Med Assoc J 119:334–338, 1978

    PubMed  CAS  Google Scholar 

  116. Jones LM, Spector SL, English GM, Taylor-Dawson K: Treatment of perennial rhinitis with flunisolide corticosteroid spray. Ann Allergy 42:139–144, 1979

    PubMed  CAS  Google Scholar 

  117. Pipkorn U, Rundcrantz H: Budesonide and beclomethasone dipropionate in hay fever—a single blind comparison. Eur J Respir Dis 63 (suppl 122):211–220, 1982

    Google Scholar 

  118. Balle VH: The effect of budesonide in perennial rhinitis. Eur J Respir Dis 63 (Suppl 122):197–204, 1982

    Google Scholar 

  119. Sorensen H, Mygind N, Pedersen CB, Prytz S: Long-term treatment of nasal polyps with beclomethasone dipropionate aerosol. Acta Otolaryngol 82:260–262, 1976

    Article  PubMed  CAS  Google Scholar 

  120. Goadby P, Smith WG: Observations on the anti-anaphylactic activity of hydrocortisone and related steroids. J Pharm Pharmacol 16:108–114, 1964

    PubMed  CAS  Google Scholar 

  121. Cline MJ, Melman KL: Plasma kinins and cortisol: A possible explanation of the antiinflammatory action of Cortisol. Science 153:1135–1138, 1966

    Article  PubMed  CAS  Google Scholar 

  122. Pipkorn U: Effect of topical glucocorticoid treatment on nasal mucosal mast cells in allergic rhinitis. Allergy 38:125–129, 1983

    Article  PubMed  CAS  Google Scholar 

  123. Malm L, Wihl JA, Lamm CJ, Lindqvist N: Reduction of metacholine-induced nasal secretion by treatment with a new topical steroid in perennial non-allergic rhinitis. Allergy 36:209–214, 1981

    Article  PubMed  CAS  Google Scholar 

  124. Harris DM: Some properties of beclomethasone dipropionate and related steroids in man. Postgrad Med J 51 (suppl):20–25, 1975

    PubMed  CAS  Google Scholar 

  125. Johnsson S-A, Andersson K-E, Brattsand R, Gruvstad E, Hedner P: Topical and systemic glucocorticoid potencies of budesonide, beclomethasone dipropionate and prednisolone in man. Eur J Respir Dis 63 (Suppl 122):74–82, 1982

    Google Scholar 

  126. Chaplin MD, Cooper WC, Segre EJ, Oren J, Jones RE, Nerenberg C: Correlation of flunisolide plasma levels to eosinopenic response in humans. J Allergy Clin Immunol 65:445–153, 1980

    Article  PubMed  CAS  Google Scholar 

  127. Harris DM, Martin LE, Harrison C, Jack D: The effect of intranasal beclomethasone dipropionate on adrenal function. Clin Allergy 4:291–294, 1974

    Article  PubMed  CAS  Google Scholar 

  128. Pipkorn U: Budesonide and nasal histamine challenge. Allergy 37:359–363, 1982

    Article  PubMed  CAS  Google Scholar 

  129. Mygind N, Johnsen NJ, Thomsen J: Intranasal allergen challenge during corticosteroid treatment. Clin Allergy 7:69–74, 1977

    Article  PubMed  CAS  Google Scholar 

  130. Munch EP, Weeke B, Johansson S-A: The effect of budesonide on nasal allergen challenge in patients with seasonal rhinitis and on nasal peak flow in healthy volunteers. Eur J Respir Dis 63 (Suppl 122):176–184, 1982

    Google Scholar 

  131. Pedersen CB, Mygind N, Sorensen H, Prytz S: Long-term treatment of nasal polyps with beclomethasone dipropionate aerosol. II. Clinical results. Acta Otolaryngol 82:256–259, 1976

    Article  PubMed  CAS  Google Scholar 

  132. Mygind N, Sorensen H, Pedersen CB: The nasal mucosa during long-term treatment with beclomethasone dipropionate aerosol. Acta Otolaryngol 85:437–443, 1978

    PubMed  CAS  Google Scholar 

  133. Harding SM, Heath S: Intranasal steroid aerosol in perennial rhinitis: Comparison with an antihistamine compound. Clin Allergy 6:369–372, 1976

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. From the Faculties of Medicine and Pharmacy, The University of Manitoba, Winnipeg, Manitoba, Canada

    F. Estelle R. Simons & Keith J. Simons

Authors
  1. F. Estelle R. Simons
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Keith J. Simons
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Simons, F.E.R., Simons, K.J. Pharmacologic treatment of rhinitis. Clin Rev Allergy 2, 237–253 (1984). https://doi.org/10.1007/BF02991103

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02991103

Keywords

Search

Navigation